Cell-El Survey
Cell-El is asking parents of children diagnosed on the autism spectrum to fill out this short survey. Why? Researchers at Cell-El would like to develop a blood test that will enable parents to receive an early diagnosis. This will enable their children to start therapy at a young age.
Therapy
Autism spectrum disorder (ASD) is a developmental disorder, characterized by deficits in communication, social interactions and sensory perception and by repetitive behavior, typically manifesting in the first three years of life. No curative therapies are available to treat the condition, whose causes remain poorly understood.
Meet Our Team: Dr. Lazar Friedman
In his presentation Dr Friedman discusses current issues in ASD – the clinical features of the disorder and its epidemiology (the study of how often diseases occur in different groups of people and why) and clinical features of ASD.
Personalized Medicine for ASD
Our approach has expanded to analyze proteomic biomarkers as a way to identify ASD in younger children. Cell-El researchers envision that this approach has the potential to guide treatment outcomes.
Biomarkers for ASD
We at Cell- El Ltd. are focusing our research on biomarkers in the blood, stool, and urine of children with Autism Spectrum Disorders (ASD).
SC Treatment In Older Children
Cell-El researchers chose to broaden our biomarker analysis from 2–12 year-olds undergoing Stem Cell Therapy (SCT) to include children and young adults aged 13-18. The rationale for including this new population is to understand if such therapy can affect older children who in theory have less brain plasticity.
Mesenchymal Stem Cells
This article presents the rationale behind stem cell-based treatment for autism patients due to immune and nervous system abnormalities. This approach has proven to be both effective and safe.